Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath Publishes Winter 2026 Issue of Alumni Journal

Read More

News & Insights

Arrangement of Financing for TPG’s Acquisition of Vertafore

June 15, 2010

On June 10, 2010, Vertafore, a leading provider of software and services to the insurance industry, announced a definitive merger agreement in which the company will be acquired by investment funds managed by TPG Capital (“TPG”) for a total consideration of $1.4 billion. TPG will purchase the company from Hellman & Friedman and its co-investor JMI Equity. Cravath advised Credit Suisse, BofA Merrill Lynch and Barclays Capital on financing matters in connection with this transaction. The acquisition is expected to close in the third quarter, subject to customary regulatory approvals.

The Cravath team includes partners Michael S. Goldman, James C. Vardell, III and Craig F. Arcella; senior attorney Christopher J. Kelly; associates B.J. Rosen, Rose Stella, Aaron M. Golden and Helen O. Ogbara; and summer associate Eva S. Hibnick.

Related Practices & Industries

  • Corporate
  • Private Equity
  • Technology

People

Photo
Name
Craig F. Arcella
Title
Corporate
Title
Partner
Email
carcella@cravath.com
Phone
+1-212-474-1024
vCard
Download vCard

    Education

    • J.D., 1998, Columbia Law School
      Harlan Fiske Stone Scholar
    • B.A., 1995, Duke University

    Admitted In

    • New York
    Photo
    Name
    Christopher J. Kelly
    Title
    Corporate
    Title
    Partner
    Email
    cjkelly@cravath.com
    Phone
    +1-212-474-1406
    vCard
    Download vCard

      Education

      • J.D., 1999, Harvard Law School
      • B.A., 1996, Columbia University
        Phi Beta Kappa, summa cum laude

      Admitted In

      • New York
      Photo
      Name
      Michael S. Goldman
      Title
      Corporate
      Title
      Retired Partner
      Email
      mgoldman@cravath.com
      Phone
      +1-212-474-1999
      vCard
      Download vCard

        Education

        • J.D., 1987, Fordham University School of Law
          cum laude
        • B.A., 1984, University of Pennsylvania
          cum laude

        Related News & Insights

        Deals & Cases

        April 06, 2026

        Versigent’s $1.35 Billion Credit Facilities and $1.6 Billion High‑Yield Senior Notes Offering in Connection with Aptiv PLC’s Spin‑Off of Versigent

        Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $1.35 billion of credit facilities made available to subsidiaries of Versigent Limited, a global leader in the design, development and manufacture of low voltage and high voltage electrical architectures and the holding company for Aptiv PLC’s Electrical Distribution Systems segment, which Aptiv PLC spun off into a separate, independent, publicly traded company. The proceeds were used to partially finance the spin‑off. The credit facilities consisted of a $500 million term loan facility and an $850 million revolving credit facility. The transaction closed on November 26, 2025.

        Deals & Cases

        February 20, 2026

        First Solar’s $1.5 Billion Revolving Credit Facility

        Cravath represented First Solar, Inc. in connection with its $1.5 billion revolving credit facility. First Solar is America’s leading photovoltaic solar technology and manufacturing company, and the only US‑headquartered company among the world’s largest solar manufacturers. The transaction closed on February 13, 2026.

        Deals & Cases

        January 08, 2026

        Genmab’s $3.5 Billion of Credit Facilities and Offering of $1.5 Billion Senior Secured Notes and $1 Billion Senior Unsecured Notes in Connection with its Acquisition of Merus

        Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $3.5 billion of credit facilities made available to Genmab, a leading international biotechnology company, and one of its wholly‑owned subsidiaries, Genmab Finance LLC, as part of the financing transactions undertaken in connection with its acquisition of Merus N.V., a leading oncology company developing innovative antibody therapeutics. The credit facilities consisted of a $2 billion term loan “B” facility, a $1 billion term loan “A” facility and a $500 million revolving credit facility. The transaction closed on December 12, 2025.

        Deals & Cases

        December 24, 2025

        Ameren’s $3.2 Billion of Revolving Credit Facilities

        Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with $3.2 billion of revolving credit facilities made available to Ameren Corporation and Union Electric Company (the “Missouri Borrowers”) and Ameren Corporation and Ameren Illinois Company (the “Illinois Borrowers”). Ameren Corporation is an American power company that engages in the rate‑regulated electric generation, transmission and distribution activities; and rate‑regulated natural gas distribution and transmission businesses. The facilities consisted of a $1.9 billion revolving credit facility (Missouri Borrowers) and $1.3 billion revolving credit facility (Illinois Borrowers). The transaction closed on December 10, 2025.

        Cravath Bicentennial

        Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

        Explore

        Cravath, Swaine & Moore LLP Logo
        • CONTACT US
        • OUR STORY
        • ALUMNI PORTAL
        • DISCLAIMERS & NOTICES

        Attorney Advertising. ©2026 Cravath, Swaine & Moore LLP.